Kelly Kristin N, Domajnko Bastian
Department of Surgery, University of Rochester Medical Center, Rochester, New York.
Department of Surgery, University of Rochester Medical Center, Rochester, New York ; Rochester Colon & Rectal Surgeons, P.C., Rochester, New York.
Clin Colon Rectal Surg. 2013 Sep;26(3):163-7. doi: 10.1055/s-0033-1351132.
Supraphysiologic corticosteroid doses have routinely been considered the perioperative standard of care over the past six decades for patients on long-term steroid therapy. However, the accumulation of data over this period is beginning to suggest that such a practice may not be necessary. The majority of these studies are retrospective reviews or small prospective cohorts, but there are two small prospective, randomized placebo-controlled trials, one prospective primate trial, and several systematic reviews addressing the issue. Based on this developing evidence, patients on long-term exogenous steroids do not require high-dose perioperative corticosteroids and should instead remain on their baseline maintenance dose, with the understanding that secondary adrenal insufficiency should be considered for unexplained perioperative hypotension in these patients.
在过去的六十年里,超生理剂量的皮质类固醇一直被常规视为长期接受类固醇治疗患者围手术期的标准治疗方法。然而,这段时间积累的数据开始表明,这种做法可能没有必要。这些研究大多是回顾性综述或小型前瞻性队列研究,但有两项小型前瞻性随机安慰剂对照试验、一项前瞻性灵长类动物试验以及几项针对该问题的系统评价。基于这一不断发展的证据,长期接受外源性类固醇治疗的患者围手术期不需要高剂量皮质类固醇,而应维持其基线维持剂量,同时要明白,对于这些患者围手术期出现的不明原因低血压,应考虑继发性肾上腺功能不全。